Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00526136
Status:
COMPLETED
Last Update Posted:
2008-12-18
First Post:
2007-09-05
Brief Title:
Vernakalant Oral Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Sponsor:
Advanz Pharma
Organization:
Advanz Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-05
First Submit QC Date:
September 6 2007
Study First Post Date:
2007-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-12-17
Last Update Post Date:
2008-12-18
Last Update Post Date Type:
ESTIMATED